Florida Board of Medicine to Reconsider Telemedicine Weight Loss Rule

26 July 2021 Health Care Law Today Blog
Author(s): Nathaniel M. Lacktman

The Florida Board of Medicine will hold a rule development workshop to discuss updating the provisions of its rule for prescribing obesity drugs.  Under the current rule (Florida Administrative Code 64B8-9.012), a physician who prescribes, orders, or provides weight loss enhancers must have the patient undergo an in-person exam within 2 to 4 weeks of receiving a prescription, order, or dosage.  This in-person requirement has limited the use of telemedicine in Florida for clinical weight loss treatment.

Initially enacted in 1998, the rule has not been revised in more than 20 years.  The decision to revisit the rule follows Florida’s enactment of sweeping telemedicine legislation in 2019, transforming clinicians’ ability to use virtual care services when treating patients.  The law prompted the Medical Board to revisit its prior telemedicine practice rules, with this weight loss rule being the most recent. 

Read a copy of our comments here.

Rulemaking Workshop and Public Comments

The rulemaking workshop will be held on August 5, 2021 at 4955 Kyngs Heath Road, Kissimmee, Florida.  The public is invited to offer comments in person or via written submission.  Written submissions should be provided to the Board in advance of the workshop at the following email address: BOM.MeetingMaterials@flhealth.gov.

Want to Learn More?

For more information on telemedicine, telehealth, virtual care, remote patient monitoring, digital health, and other health innovations, including the team, publications, and representative experience, visit Foley’s Telemedicine & Digital Health Industry Team. 

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.